Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2010
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732481 Prolinylarylacetamides
06/08/2010US7732466 5-chloro-thiophene-2-carboxylic acid-N-{1-[3-chloro-4-(pyrrolidin-1-yl-carbonyl)-phenylcarbamoly]-ethyl}-amide, having antithrombotic activity and blood-coagulation factor Xa inhibiting activity
06/08/2010US7732457 enzyme inhibitors such as 6-{2-(2-Chloro-phenyl)-5-[4-(pyrimidin-2-yloxy)-phenyl]pyrrol-1-ylmethyl}-pyridin-2-ylamine, used to treat beta-amyloid deposits and neurofibrillary tangles; Alzheimer's disease
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests
06/08/2010US7732445 Pyridazinyl compounds such as 11-(6-imino-3-phenylpyridazin-1(6H)-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-undecanamide, use for the treatment of tissue barrier dysfunction, tumor metastasis and related disease states
06/08/2010US7732444 4-{2-[4-(3-{[(3-Amino-propyl)-ethyl-amino]-methyl}-phenyl)-pyrimidin-2-ylamino]-ethyl}-phenol, used as protein kinase C inhibitors
06/08/2010US7732438 CGRP receptor antagonists
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2416442C Substituted 5-alkynyl pyrimidines having neurotrophic activity
06/08/2010CA2369404C Method of producing nitroguanidine- and nitroenamine derivatives
06/03/2010WO2010062245A1 Spirocyclobutyl piperidine derivatives
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061587A1 Anthrapyridone compound, salt thereof, magenta ink composition and colored body
06/03/2010WO2010061209A1 A crystalline form of lenalidomide and a process for its preparation
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010060955A1 Novel 2-morpholino-3-amido-pyridine derivatives and their medical use
06/03/2010WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
06/03/2010WO2010060379A1 Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof
06/03/2010WO2010014257A3 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/03/2010WO2010005692A4 Insecticidal cyclic carbonyl amidines
06/03/2010WO2009158257A3 Fungicidal pyridines
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010WO2009109654A8 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010US20100137607 Barium salt of benzimidazole derivative
06/03/2010US20100137606 Novel compound having beta-secretase inhibitory activity
06/03/2010US20100137601 Thiazolylimidazole derivatives an their use as inhibitors of microsomal triglyceride transfer protein
06/03/2010US20100137600 Photogenerated reagents
06/03/2010US20100137594 Tetrazoyloxime derivative and plant disease control agent
06/03/2010US20100137590 N[S(4-ARYL-TRIAZOL-3-YL)alpha-MERCAPTOACETYL] -P-AMINO BENZOIC ACIDS AS HIV REVERSE TRANSCRIPTASE INHIBITORS
06/03/2010US20100137582 N-pyridylpiperidine compound, method for producing the same, and pest control agent
06/03/2010US20100137469 Aziridine-functional photoactive crosslinking compounds
06/03/2010US20100137367 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137362 Heterocyclic hydrazide compound and pesticidal use of the same
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137338 INHIBITORS OF Akt ACTIVITY
06/03/2010US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/03/2010US20100137332 Piperazine modulators of nk-1 receptors
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/03/2010US20100137325 Biphenyl compounds useful as muscarinic receptor antagonists
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137315 Sphingosine Kinase Inhibitors and Methods of Their Use
06/03/2010US20100137313 Heterocyclic derivatives and methods of use thereof
06/03/2010US20100137309 Fungicides phenyl-pyrimidnyl-amino derivatives
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137285 Small molecule modulators of cytokine activity
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137278 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/03/2010US20100137277 Pyridine compounds and their use as p2y12 antagonists
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100136524 Target protein and target gene in drug designing and screening method
06/03/2010US20100136136 JAK-2 Modulators and Methods of Use
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135960 Antiviral acylsulfonamide derivatives
06/03/2010US20100135954 6-Phenylpyrimidinones as PIM Modulators
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2743018A1 Substituted pyrazole compounds
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/03/2010CA2741927A1 A crystalline form of lenalidomide and a process for its preparation
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2190836A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
06/02/2010EP2190835A1 Adrenergic compounds
06/02/2010EP2190834A1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190825A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2190823A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides
06/02/2010EP2190822A2 5-membered heterocyclic compounds as proton pump inhibitors
06/02/2010EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
06/02/2010EP2190534A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
06/02/2010EP2001478B1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
06/02/2010EP1853581B1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010EP1417200B1 Substituted 1h-dihydropyrazoles, their preparation and use
06/02/2010EP1416797B1 Arthropodicidal anthranilamides
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN101720323A Compounds with anti-cancer activity
06/02/2010CN101720322A Compounds and compositions as c-kit and pdgfr kinase inhibitors
06/02/2010CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors
06/02/2010CN101717395A Synthesis method of chlorantraniliprole pesticide
06/02/2010CN101717394A Preparation method and use of compound having insecticidal activity
06/02/2010CN101348463B Synthetic method of argatroban and intermediate thereof
06/02/2010CN101225601B Multifunctional reactive cotton ultraviolet absorbent, synthetic method and use thereof
06/02/2010CN101157684B Aspartic acid lomefloxacin hydrate and preparation and uses thereof
06/02/2010CN101035761B 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt